Pages

Total Pageviews

Friday, September 23, 2016

Now, a pill that promises to melt away leukaemia

A new drug that 'melts' away cancer has been given fast-track approval in the US. Developed in Melbourne, Australia, Venetoclax was developed to specifically target chronic lymphocytic leukaemia.

The drug showed a positive result in 80% of clinical trials, with one in five patients finishing the programme completely cancer-free. Venetoclax is administered orally every day via a pill.

In the original trial, 116 participants increased their dosage from 20mg to 400mg over a five-week period.

No comments:

Post a Comment